KLK2 and prostate carcinoma: It is noteworthy that KLK2 featured recurring significantly in our assessment: it is the most strongly downregulated DEGSD, a member of the “prostate cancer” pathway, a putative prostate-specific marker and it is involved in the hormonal axis of PCa.